Improving The Awareness Of Cervical Cancer

The women in my family including myself were all diagnosed between 25 and 32. This was not a normal age to be diagnosed but it is becoming

The U.S. Preventative Services Task Force (USPSTF) recommends cervical cancer screening with cytology testing (also known as a Pap Smear) every three years in women ages 21 to 65 (U.S. Preventative Services Task Force [USPSTF], 2016a). The USPSTF has graded this recommendation with an “A” indicating that they have a high level of certainty that the screening will prove to be beneficial, rather than harmful to the patient (USPSTF, 2016a). However, if this patient would prefer to receive cervical cancer screening every five years, the USPSTF also has a high level of certainty that this will prove to beneficial rather than harmful if human papillomavirus (HPV) and cytology are both performed during this screening (USPSTF, 2016a). The

Cervical cancer is when there are malignant cells present in the cervix; it is developed in the lining of the cervix. A cervix is a narrow opening located at the bottom of the uterus that leads into the vagina. Cervical cancer mostly affects women between the ages of 40 and 55. This cancer can be prevented by screening for precancerous cells, and it can also be cured if it is detected at an early stage. Over the past few decades the number of cervical cancer cases has declined dramatically due to a more widespread screening of the disease. Today, it is estimated that 10,000 new

Reality: "Between the ages of 15 and 45, close to 90% of diagnosed patients are women

II. However, that means that one in 300 children will battle this disease in their lifetime.

percent two years ago. This disease is unquestionably one of the worst and most confusing

Early detection of breast and cervical cancer reduced the burden of disease in women. The practices of Screening shown reduce the level of mortality and improve quality of life. The Every Woman Matters (EWM)stared in 1992 it is a federally-funded program designed to remove barrier to early screening by providing awareness and make screening more financially accessible to woman who have limited or no health insurance. The eligible women receive pay for office visits with associated clinical breast examination, pelvic examination, Papanicolaou smear test, and lab fees (Backer et al., 2004). Age-appropriate mammography and limited number of diagnostic test is also covered under program. In this paper I will

Center for Disease Control and Prevention (CDC's) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access to breast and cervical cancer screening to underserved women in all 50 states. NBCCEDP programs use population-based approaches such as public education, patient navigation, and outreach, care coordination to increase screening and reach underserved and uninsured populations. This program provides cervical screening for 21 to 64 year and breast screening for 40 to 64 years. Since this program initiated in 1991 almost 3.7 million women has been screened and 44,885 cases of breast cancer, 2,554 cervical cancers and123, 563 cervical precursor lesions have been detected (Benard et.al , 2011). NBCCEDP use Conceptual Framework supports a collection of strategies to reach uninsured women, including program controlling, screening and diagnostic services. Team members of the NBCCEDP work collaboratively to provide breast and cervical cancer screening, diagnostic evaluation, treatment and referrals. “The program's continued success depends in large part on the complementary efforts of a variety of national partner organizations, as well as on state and community partners” (CDC, 2012). The key success for these two cancer screening programmes

The study was a secondary data analysis of existing patient records (record-based). This study made use of the National Inpatient Sample (NIS) Database .The NIS database was developed by the Healthcare Cost and Utilization Project (HCUP). The NIS is the largest inpatient care database in the United States containing data from 1988 to 2013. It includes about 98 percent of all hospital discharges in the United States. NIS is a sample of hospitals that comprises approximately 95 percent of all hospital discharges in the United States. It consists of over hundred nonclinical and clinical data elements for each hospital stay. The four most recent available calendar years (2010 to 2013) were obtained for the analyses of cervical cancer mortality

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

Cervical cancer remains a public health problem that affects women worldwide. Cervical cancer is rated as the fourth type of cancer worldwide and the second most common cancer in women living in developing countries. In Europe, cervical cancer ranks as the sixth leading cancer of female cancers and second most common cancer among women aged between 15 to 44 years of age. Early detection and treatment are important for the prevention of morbidity and mortality related to cervical cancer. International studies conducted suggest that cervical cancer-related morbidity and mortality are highest among immigrant populations and that immigrant women may be less likely than non-immigrant women to participate in cervical cancer screening. These studies indicate that Somali women, in particular, constitute one immigrant group that is less likely to participate in cervical cancer screening. However, little information is known about the perceptions of and perspectives on cervical cancer screening as well as the barriers to uptake of cervical cancer screening among Somali women in Oslo. The aim of the study is to explore perceptions of and

breast cancer from twenty five to thirty percent and women age forty the data states a

In the United States, it is one of the eight-most common cancer of women. According to researches, the data shows that Hispanic women are significantly more likely to be diagnosed with cervical cancer than the general population and their median age at diagnosis is 48. In 1998, about 12,800 women were diagnosed in the US and about 4,800 died. Among cancers of the female reproductive tract, it is less common than endometrial cancer and ovarian cancer. The rates of new cases in the United States was 7 per 100,000 women in 2004. Cervical cancer deaths decreased by approximately 74% in the

2. Within the current year of 2016, an estimate of 1,500 women in the United States will be diagnosed with cervical cancer and an estimate of 400 deaths will occur this year from this

Cervical cancer is one of the leading causes of cancer related mortality in countries such as India accounting for more than 17% of all cancer deaths in women aged 30-69. [3] Cervical cancer is one such type of cancer in which screening plays a significant role. Clinical trials done in below poverty level populations do encounter ethical issues to a certain extent with regards to informed consent as most or all of these patients are illiterate. However informed consent is extremely important when justifying data for such clinical trials. Countries such as US have implemented Pap smear screening as one of the most important cervical cancer screening methods. In countries as densely populated as India where proper healthcare facilities does not reach slums and extremely poverty stricken societies, alternatives for screening are indicated- VIA or Visual inspection with acetic acid